Dashboard
Manage Tickers

NLSPNLS Pharmaceutics Ltd.

Nasdaq nlspharma.com


$ 0.13 $ 0.00 (0.59 %)    

Friday, 13-Sep-2024 09:59:07 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 0.136
-- x --
-- x --
-- - --
$ 0.11 - $ 1.02
174,671
na
4.85M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dow-edges-lower-ventyx-biosciences-shares-plummet
Dow Edges Lower; Ventyx Biosciences Shares...
07/29/2024 18:31:47

why-bank-of-marin-bancorp-shares-are-trading-lower-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Bank of Marin Bancorp Shares Are Tradi...
07/29/2024 17:19:13

crude-oil-moves-lower-nls-pharmaceutics-shares-jump
Crude Oil Moves Lower; NLS Pharmaceutics S...
07/29/2024 16:03:54

nls-pharmaceutics-and-kadimastem-enter-binding-term-sheet-for-transaction-under-which-kadimastem-will-become-a-wholly-owned-subsidiary-of-nls-kadimastems-shareholders-to-hold-85-of-issued-and-outstanding-shares-of-merged-company
NLS Pharmaceutics And Kadimastem Enter Bin...
07/29/2024 11:08:43

trading-halt-halted-at-65651-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 6:56:51 a.m. ET - ...
07/29/2024 10:56:55

nls-pharmaceutics-annnounced-registered-direct-offering-of-3277750-shares-at-024share
NLS Pharmaceutics Annnounced Registered Di...
06/28/2024 13:22:46

nls-pharmaceutics-highlights-preclinical-results-for-parkinsons-disease-treatments
NLS Pharmaceutics Highlights Preclinical R...
06/27/2024 12:22:59

Key findingsAEX-23: Its pronounced action as an OX1R agonist combined with positive effects on neurite outgrowth at specific co...

why-jabil-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Jabil Shares Are Trading Lower By 8%? ...
06/20/2024 17:26:29

dow-edges-lower-us-current-account-deficit-widens-in-q1
Dow Edges Lower; US Current Account Defici...
06/20/2024 13:42:46

why-vuzix-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Vuzix Shares Are Trading Higher By Aro...
06/20/2024 12:22:52

why-quantum-shares-are-trading-lower-by-45-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Quantum Shares Are Trading Lower By 45...
06/18/2024 17:39:53

us-stocks-mixed-retail-sales-increase-01-in-may
US Stocks Mixed; Retail Sales Increase 0.1...
06/18/2024 14:11:36

why-chegg-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket
Why Chegg Shares Are Trading Higher By Aro...
06/18/2024 09:28:13

Core News & Articles
NLS Pharmaceutics Announces Publication Of...
06/11/2024 12:35:39

NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmace...

Core News & Articles
NLS Pharmaceutics Reports Results From Stu...
05/28/2024 12:07:51

NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmace...

nls-pharmaceutics-announces-175m-registered-direct-offering-of-7m-shares-at-025share
NLS Pharmaceutics Announces $1.75M Registe...
03/20/2024 17:49:35

nls-pharmaceutics-secures-exclusive-global-license-for-next-generation-non-sulfonamide-dual-orexin-agonist-platform
NLS Pharmaceutics Secures Exclusive Global...
03/20/2024 11:39:23

nls-pharmaceutics-has-been-notified-by-the-listing-qualifications-department-of-the-nasdaq-stock-market-that-the-companys-plan-to-regain-compliance-submitted-on-february-23-2024-has-been-approved
NLS Pharmaceutics Has Been Notified By The...
03/11/2024 11:38:00

nls-pharmaceutics-says-it-submited-plan-to-regain-listing-compliance-with-nasdaq
NLS Pharmaceutics Says It Submited Plan To...
02/23/2024 12:45:06

nls-pharmaceutics-announced-nasdaq-letter-related-to-continued-listing-requirements
NLS Pharmaceutics Announced Nasdaq Letter ...
01/12/2024 21:33:42

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION